Cancer

We have a clear aspiration – to transform the lives of people with cancer by delivering meaningful advances, with the ultimate goal of curing a range of cancers. Our generational commitment to driving scientific innovation is reflected by our robust pipeline of cancer cell-directed and immuno-oncology investigational therapies, as well as the smart combination of these approaches. We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research. Simply put, for Boehringer Ingelheim, cancer care is personal, today and for generations.

scientists working in a lab
Hand touching grass with text "Little Things Can Feel Big When You Are Living with Cancer"

Celebrating the Big Little Things

Little things can be a big deal when you are living with or treating cancer. “Big Little Things” celebrates the small things that have a big impact.

Two hands in the shape of a heart

Why cancer care is personal for us

At Boehringer Ingelheim, we have made a generational commitment to transforming cancer care, with the ultimate goal of curing a range of cancers.

Patients with a rare and aggressive form of liposarcoma need treatment advances
mehdi lahmar and his team
Cancer

Patients with a rare and aggressive form of liposarcoma need treatment advances

Mehdi Lahmar, Clinical Program Leader in Oncology at Boehringer Ingelheim discusses the role that our investigational MDM2-p53 antagonist plays in rare types of soft tissue sarcoma and the launch of the Brightline-1 clinical trial.
Read more
Sarcoma: An expert’s perspective
Dr. Schwartz shares his sarcoma perspective
Cancer

Sarcoma: An expert’s perspective

Hear from Gary Schwartz, MD, Director of the Case Comprehensive Cancer Center, Cleveland, Ohio.
Read more
Exploring T-cells in cancer
Lamine Mbow on our approach to Immuno-oncology
Cancer

Exploring T-cells in cancer

Lamine Mbow, our Global Head of Cancer Immunology and Immune Modulation, shares our approach to immuno-oncology highlighting our cancer research and how we are driving innovation to deliver meaningful advances to people with cancer.
Read more